Bipartisan House bill seeks new $30B ‘BioBonds’ loan program to reinvigorate clinical trials
As thousands of clinical trials were suspended or halted due to the Covid-19 pandemic over the last year, House members on both sides of the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
